We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M Turnover 17.39%
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$314M
AUM Growth
+$10.3M
Cap. Flow
-$3.56M
Cap. Flow %
-1.14%
Top 10 Hldgs %
73.99%
Holding
80
New
20
Increased
31
Reduced
6
Closed
14
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
1.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.96%
2 Financials 13.61%
3 Healthcare 12.52%
4 Communication Services 6.16%
5 Technology 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$138M 44.05%
550,000
+70,000
+15% +$17.3M
2014 Q1
14 quarters
GS icon
2
Goldman Sachs
GS
$228B
$19.5M 6.21%
82,176
-511
-0.6% -$115K
2015 Q3
8 quarters
HCA icon
3
HCA Healthcare
HCA
$99.3B
$12.8M 4.07%
160,490
+4
+0% +$322
2014 Q4
11 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$3.25T
$11.9M 3.79%
248,100
+2,480
+1% +$116K
2014 Q3
12 quarters
JPM icon
5
JPMorgan Chase
JPM
$825B
$11.2M 3.58%
117,565
-94
-0.1% -$8.67K
2016 Q1
6 quarters
NEOS
6
DELISTED
Neos Therapeutics
NEOS
$9.6M 3.04%
1,043,770
– –
2015 Q3
8 quarters
APTV icon
7
Aptiv
APTV
$7.15B
$7.38M 2.35%
75,000
– –
2016 Q1
6 quarters
APTV icon
8
PUT
Aptiv
APTV
$7.15B
$7.38M 2.35%
+75,000
New +$7.08M
2017 Q3
0 quarters
BERY icon
9
DELISTED
Berry Global Group
BERY
$7.36M 2.35%
141,570
– –
2015 Q3
8 quarters
ATH
10
DELISTED
Athene Holding
ATH
$6.86M 2.19%
127,419
– –
2016 Q4
3 quarters
ZVRA icon
11
Zevra Therapeutics
ZVRA
$521M
$6.63M 2.11%
111,977
+20,777
+23% +$1.11M
2015 Q2
9 quarters
FOMX
12
DELISTED
Foamix Pharmaceuticals
FOMX
$6.59M 2.1%
1,187,604
+950
+0.1% +$4.91K
2014 Q3
12 quarters
GS icon
13
PUT
Goldman Sachs
GS
$228B
$5.93M 1.89%
25,000
-55,000
-69% -$12.4M
2016 Q4
3 quarters
TEL icon
14
TE Connectivity
TEL
$57.3B
$5.23M 1.67%
63,000
– –
2016 Q2
5 quarters
PARA icon
15
DELISTED
Paramount Global Class B
PARA
$4.93M 1.57%
85,000
– –
2015 Q4
7 quarters
XBI icon
16
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.5B
$4.33M 1.38%
50,000
– –
2017 Q2
1 quarter
TLT icon
17
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$47.7B
$3.93M 1.25%
+31,500
New +$3.96M
2017 Q3
0 quarters
QQQ icon
18
PUT
Invesco QQQ Trust
QQQ
$418B
$3.64M 1.16%
+25,000
New +$3.58M
2017 Q3
0 quarters
NSTG
19
DELISTED
NanoString Technologies
NSTG
$2.67M 0.85%
165,000
-161,006
-49% -$2.48M
2015 Q2
9 quarters
GLD icon
20
SPDR Gold Trust
GLD
$118B
$2.66M 0.85%
+21,860
New +$2.66M
2017 Q3
0 quarters
DFS icon
21
DELISTED
Discover Financial Services
DFS
$2.45M 0.78%
+38,000
New +$2.3M
2017 Q3
0 quarters
HCA icon
22
CALL
HCA Healthcare
HCA
$99.3B
$2.39M 0.76%
+30,000
New +$2.41M
2017 Q3
0 quarters
PARA icon
23
CALL
DELISTED
Paramount Global Class B
PARA
$2.03M 0.65%
+35,000
New +$2.21M
2017 Q3
0 quarters
IWN icon
24
iShares Russell 2000 Value ETF
IWN
$13.1B
$1.98M 0.63%
15,960
+5,520
+53% +$651K
2017 Q2
1 quarter
MSFT icon
25
Microsoft
MSFT
$3.6T
$1.34M 0.43%
17,995
+5,499
+44% +$402K
2014 Q2
13 quarters

Similar funds

DSC Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, DSC Advisors held 80 positions worth $314M, up 3.4% from $303M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DSC Advisors's Q3 2017 filing shows 20 new, 31 increased, 6 reduced and 14 closed positions. Its largest new stake was SPDR Gold Trust: 21,860 shares worth $2.66M. The largest sale was CVS Health, an estimated $6.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 58% a quarter earlier, followed by Financials and Healthcare.

  • DSC Advisors's largest Q3 2017 buy was SPDR Gold Trust: 21,860 shares worth $2.66M.
  • DSC Advisors added most to Zevra Therapeutics in Q3 2017, an estimated $1.11M increase.
  • DSC Advisors's biggest Q3 2017 reduction was NanoString Technologies, cutting an estimated $2.48M.
  • DSC Advisors fully exited CVS Health in Q3 2017, selling an estimated $6.5M.
  • DSC Advisors's ten largest holdings make up 74% of its $314M portfolio in Q3 2017.
  • DSC Advisors opened 20 new positions and closed 14 in Q3 2017.
  • DSC Advisors's portfolio value rose 3.4% quarter-over-quarter to $314M.

Based on DSC Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.